# FDA Inspection 1208725 - Optimus Pharma Private Limited - June 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/optimus-pharma-private-limited/66f0a7c9-2544-4107-a868-3815644a5f7e
Source feed: FDA_Inspections

> FDA Inspection 1208725 for Optimus Pharma Private Limited on June 23, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208725
- Company Name: Optimus Pharma Private Limited
- Inspection Date: 2023-06-23
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1294786 - 2025-12-11](https://www.keypedia.com/records/fda_inspections/optimus-pharma-private-limited/e2f1197e-5534-4f9f-9e5f-bf97522d4ce6)
- [FDA Inspection 1106283 - 2019-09-06](https://www.keypedia.com/records/fda_inspections/optimus-pharma-private-limited/1a1a64ce-6cdc-44c7-8d36-28ba8d6d88cb)

Company: https://www.keypedia.com/companies/optimus-pharma-private-limited/d40f7c3d-bfe2-4d92-ae82-3bd26d23f240

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c